Results 91 to 100 of about 3,943 (171)

Taming Bacterial Toxins into an Anticancer Platform. [PDF]

Biochem Biophys Res Commun
Yang C, Chen C.
europepmc   +1 more source

Bacterial Protein Toxins as Anticancer Agents: Clinical Potential of Pseudomonas and Anthrax Toxins. [PDF]

Toxins (Basel)
Misra R, Gupta R, Nayyar N, Baweja R, Sharma V, Singh Y, Baweja R.   +6 more
europepmc   +1 more source

Editorial: Combination therapies in cancer treatment: enhancing efficacy and reducing resistance. [PDF]

Front Pharmacol
Wang X, Pešić M, Podolski-Renić A.
europepmc   +1 more source

An Innovative Immunotoxin Design Against Allergy Based on the IL-33 Cytokine and the Ribotoxin α-Sarcin. [PDF]

Int J Mol Sci
Narbona J, Lázaro-Gorines R, Gutiérrez-Carmona A, López-Rodríguez JC, Villalba M, Lacadena J.   +5 more
europepmc   +1 more source

Unlocking the potential of engineered microbes in immunotoxin-based cancer therapy. [PDF]

Front Microbiol
Wang Q, Cao R, Xie Y, Zhang Z, Li X, Zhang Y, Luo H, Yao H, Xue P, Ni S.   +9 more
europepmc   +1 more source

Design and Characterization of Ricin Based Immunotoxins Against EPHA2 Receptor for Breast Cancer Therapy: An In-Silico Study. [PDF]

Iran J Pharm Res
Faraz A, Amani J, Arbabian S, Zare Karizi S, Bikhof Torbati M.   +4 more
europepmc   +1 more source

Ribosome-Inactivating Proteins from <i>Salsola soda</i> L. and <i>Saponaria officinalis</i> L. Are Promising Candidates for Targeted Therapy of Colon Cancer. [PDF]

Biomedicines
Biscotti F, Ragucci S, Bortolotti M, Falà F, Perrone C, Landi N, Bolognesi A, Di Maro A, Polito L.   +8 more
europepmc   +1 more source

Assessment of the Effects of Single-Domain Anti-Idiotypic Distribution Enhancers on the Disposition of Trastuzumab and on the Efficacy of a PE24-Trastuzumab Immunotoxin. [PDF]

Cancers (Basel)
Chen P, Zhang Y, Bordeau BM, Balthasar JP.   +3 more
europepmc   +1 more source

Evaluation of the Safety of A Novel Anti-HER2 Immunotoxin Containing Modified Fragment of <i>Pseudomonas</i> Exotoxin in BALB/C Mice. [PDF]

Iran J Biotechnol
Saadatkhah F, Hajhashemi V, Naimi A, Akbari V, Kolahdoozan M.   +4 more
europepmc   +1 more source

A conceptual exploration on the synergistic anti-tumor effects of high-order combination of OHSV2-DSTE^FAP5/CD3, CAR-T cells, and immunotoxins in hepatocellular carcinoma. [PDF]

Front Immunol
Dong S, Chen X, Li X, Wang Y, Huang Q, Li Y, Jin J, Zhu X, Zhong Y, Cai Q, Xue C, Guo F, Huang L, Feng M, Liu B, Hu S.   +15 more
europepmc   +1 more source